
Results
4
Most Popular Stocks on the market
4 companies
AFT Pharmaceuticals
Market Cap: NZ$373.3m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$3.56
7D
1.7%
1Y
39.6%
Pacific Edge
Market Cap: NZ$201.5m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.20
7D
-1.5%
1Y
56.3%
BLIS Technologies
Market Cap: NZ$19.2m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America.
BLT
NZ$0.015
7D
-6.3%
1Y
7.1%
Rua Bioscience
Market Cap: NZ$11.2m
Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.
RUA
NZ$0.033
7D
3.1%
1Y
13.8%